Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
STOUGHTON, Mass., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed...
Mental Health
Begins Dosing Mb22001 in Phase 2 Clinical Trial in World First Take-Home Microdosing Study in Patients with Depression
World-first take-home approvalsThe first doses of MB22001 have been administered in an 8 week treatment protocolVANCOUVER, BC / ACCESSWIRE /...
First Stop Health Recognized on Inc. Magazine’s 5000 Fastest-Growing Companies List
Virtual Care Company's Exceptional Growth Year-Over-Year Lands It on Inc.'s Prestigious List for Six Consecutive YearsCHICAGO, IL / ACCESSWIRE /...
New Foundation to Impact the 200,000 Severe Obstetric Lacerations That Occur During Childbirth Each Year
The SOLACE Foundation to build awareness, promote prevention, and offer support to women who have experienced a severe obstetric laceration.BIRMINGHAM,...
60 Degrees Pharmaceuticals Receives Additional U.S. Patent Covering Tafenoquine for Prevention of Plasmodium Falciparum Malaria
60P was awarded additional U.S. patent protection to further solidify its exclusive rights through 2035 for tafenoquine for prevention of...
NextGen Healthcare Selected by Community Reach Center to Serve Mental Health, Substance Abuse, and Primary Care Needs
Colorado’s First Community Mental Health Center Adopts Complete Behavioral Health Solution to Advance CareREMOTE-FIRST COMPANY/DENVER--(BUSINESS WIRE)--$NXGN #NextGenHealthcare--NextGen Healthcare, Inc. (Nasdaq:...
NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards
Award Acknowledges Excellence in Digital Marketing EffortsMALVERN, Pa., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical...
Mindbio Therapeutics First Batch of MB22001 has Been Manufactured and is Ready for Use in World First Phase 2 Take at Home Psychedelic Clinical Trials
MB22001 has been manufactured ready for use in Phase 2 clinical trialsWorld first take-home approvals for psychedelic microdosingVANCOUVER, BC /...
Found Joins the Innovators’ Network at American Heart Association Center for Health Technology & Innovation as the First Medical Weight Loss Solution Member
American Heart Association consortium advances development of evidence-based health tech solutionsAUSTIN, Texas--(BUSINESS WIRE)--Found, a medically-assisted weight loss program, today announced...
Napo Pharmaceuticals, a Jaguar Health Family Company, Reports Completion of Last Patient Last Visit for its Pivotal Phase 3 OnTarget Trial of Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea
Company on track to report top line data in late October 2023SAN FRANCISCO, CA / ACCESSWIRE / August 17, 2023...
Napo Pharmaceuticals Surveys of Neurologists, Patients, and Caregivers Regarding Amyotrophic Lateral Sclerosis (ALS) Treatment Indicate Real World Burden of Diarrhea and Potential Treatment Interruption
Jaguar Health family company Napo Pharmaceuticals focuses on essential supportive care and management of neglected toxicities in multiple complicated disease...
COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors
 Transaction led by healthcare specialist investors, TCGX and Aisling Capital$125 million financing upfront with up to an additional $160 million...
NorthShore University HealthSystem offers expanded access to treat most common prostate ailment
Highland Park Hospital adds second AquaBeam system, Swedish Hospital installs firstEVANSTON, Ill., Aug. 16, 2023 (GLOBE NEWSWIRE) -- NorthShore University...
Mental Health Technologies Announces Alliance With Meditab Software
MHT Spearheads Innovation through EHR Company PartnershipAURORA, IL / ACCESSWIRE / August 15, 2023 / Mental Health Technologies (MHT) is...
CYCLE Kids Launches Brooklyn-Based Fundraising Campaign
Non-profit to Kick Off Back-to-School Campaign with a Times Square Billboard on National Non-Profit Day CYCLE Kids A Bike Can...
60 Degrees Pharmaceuticals Registers ACLR8-LR, a Phase IIB Study of Tafenoquine for Treatment of COVID-19, on ClinicalTrials.gov
ACLR8-LR, a double-blind, randomized, placebo-controlled Phase IIB study to determine efficacy of the ARAKODA® regimen of tafenoquine in COVID-19 patients...
TFF Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Announced pricing of approximately $5 million equity financing (approximately $5.7 million if underwriter’s overallotment option is exercised in full); expected...
Mydecine Reports Financial Results for the Second Quarter of Fiscal Year 2023
VANCOUVER, British Columbia, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"),...
Zion Healing Inc. Announces $25 Million Private Placement to Fund Innovative Veterans Initiative
SAINT GEORGE, UT / ACCESSWIRE / August 14, 2023 / Zion Healing Inc. and its subsidiary, Zion Healing Development Company,...
Health Karma(R) Group Announces Partnership with OXIO Health, Inc. to offer access to Centralized Personal Health Record using Artificial Intelligence
FORT LAUDERDALE, FL / ACCESSWIRE / August 14, 2023 / MediXall Group Inc. (OTC PINK:MDXL) ("MediXall"), an innovative virtual health...